Delivery Order SPE2DB25D3005-SPE2DB25FQFWS

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ferumoxytol 510 mg/17 ml vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,351.60 and a period of performance through February 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 mL vials of the pharmaceutical product Ferumoxytol, with a ceiling value of $2,434.84 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,717.30, is for the delivery of ferumoxytol 510 mg/17 ml vials. It is a firm fixed-price contract with a period of performance through March 11, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product. The contract has a ceiling value of $3,146.04 and is a firm fixed price delivery order, with a performance period ending on May 23, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a for-profit organization that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.44, is a Firm Fixed Price delivery order for the supply of 4567887605 - FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Ferumoxytol, a 510 mg/17 ml vial, to the Defense Logistics Agency (DLA). The $3,724.60 firm fixed price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,161.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, held by...
This federal contract award is for the delivery of ferumoxytol, a 510 mg/17 ml vial of pharmaceutical medication, to the Defense Logistics Agency (DLA). The $1,630.03 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has an ultimate completion date of December 4, 2024 and was not set aside for any specific type of business. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vials, a medical product used for the treatment of iron deficiency anemia. The contract has a ceiling value of $2,398.60 and a period of performance through May 22, 2025. This contract is not designated as a set-aside. AmerisourceBergen...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQFWS
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition.

AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:52 PM